市場調査レポート

ハイブリッド手術室の世界市場:企業プロファイル・市場シェア・市場動向・市場規模・市場機会の分析・予測

Global Hybrid Operating Rooms Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 344789
出版日 ページ情報 英文 212 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
ハイブリッド手術室の世界市場:企業プロファイル・市場シェア・市場動向・市場規模・市場機会の分析・予測 Global Hybrid Operating Rooms Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022
出版日: 2016年02月28日 ページ情報: 英文 212 Pages
概要

世界のハイブリッド手術室の市場は2015年から2020年にかけて16.66%のCAGRで成長すると予測されています。最小侵襲手術の需要の拡大や医療部門における各種技術の進歩などが同市場の主な推進因子となっています。

当レポートでは、世界のハイブリッド手術室の市場について調査し、市場の定義・概要、バリューチェーン、市場成長への各種影響因子および市場機会の分析、用途・デバイス区分・地域/主要国別の動向および市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 市場概要

  • 定義
  • 主要調査結果
  • 主な購買基準
  • バリューチェーン分析

第3章 市場決定因子

  • 導入推進因子
  • 市場の障壁
  • 市場機会

第4章 市場分析:用途別

  • 治療
    • 心血管系手術室
    • 神経外科
    • 胸部外科
    • 生検
    • 整形外科
    • 腹腔鏡外科手術
    • 救急医療
    • その他
  • 診断画像
    • X線透視
    • DSA (デジタルサブトラクション血管造影撮影)
    • Cアーム3D CT

第5章 市場分析:デバイス別

  • 手術台
    • 移動型手術台
    • 固定型手術台
  • 手術室照明
    • 調光式照明
    • LED照明
    • ハロゲンライト
  • 手術用ブーム
  • 外科用画像ディスプレイ
  • 術中診断デバイス
    • 3D超音波
    • MRI
      • 主要ブランド・製造業者
    • CT
    • コンピュータ支援ロボット手術
    • CアームX線
    • 赤外線イメージングシステム
  • 手術室用通信システム
    • オーディオビジュアル
    • 手術室統合システム
      • WiFi
      • RFID
      • PACS

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • フランス
    • ドイツ
    • スペイン
    • イタリア
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • 韓国
  • その他の地域
    • ラテンアメリカ
      • ブラジル

第7章 競合環境

  • 主要戦略
    • 提携
    • 買収
    • 製品投入

第8章 企業プロファイル

  • Barco Nv
  • Cook Medical
  • Eschmann Equipment
  • GE Healthcare
  • Johnson & Johnson
  • Karl Storz Gmbh & Co. KG
  • Maquet Getinge Group
  • Mediflex
  • Mizuho OSI
  • NDS Surgical Imaging, LLC
  • Philips Healthcare
  • Siemens Healthcare GMBH
  • Sisco Ltd
  • Sklar
  • Skytron, LLC
  • Sontec Instruments
  • Steris Corporation
  • Stryker Corporation
  • 東芝メディカルシステムズ
  • Trumpf Gmbh + Co. KG
    • 概要
    • 製品ポートフォリオ
    • 戦略的動向
    • SCOT分析

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HAD-890415

The healthcare industry is gradually transforming from conventional operating methods to intraoperative approach for surgeries. An estimated 234 million major surgeries are performed every year globally which include cardiac catheterizations, endoscopy, neurosurgery and so on. The increasing demand for minimally invasive surgeries is driving growth of hybrid operating rooms. The growing demand for minimally invasive surgeries and various technological innovations in the healthcare industry are the major driving force for the global healthcare industry. However, high cost of establishment and safety concerns are still major challenges before the market. The market is dominated by applications in cardiovascular and neurosurgery both contributing to more than 60% of the market share.

Key companies profiled include

  • 1. Maquet Getinge Group
  • 2. Cook Medical
  • 3. GE Healthcare
  • 4. Karl Storz GmbH & Co. KG
  • 5. Eschmann Equipment
  • 6. Mizuho OSI
  • 7. TRUMPF GmbH + Co. KG
  • 8. Stryker Corporation
  • 9. Skytron, LLC
  • 10. NDS Surgical Imaging, LLC
  • 11. STERIS Corporation
  • 12. Philips Healthcare
  • 13. Siemens Healthcare
  • 14. Toshiba Healthcare
  • 15. Barco
  • 16. Johnson and Johnson
  • 17. SISCO Ltd
  • 18. Sontec Instruments
  • 19. Mediflex
  • 20. Sklar
  • This Occams Research Report covers
  • 1. Historical data
  • 2. Revenue forecasts, growth rates and CAGR upto 2022
  • 3. Industry Analysis
  • 4. Competitive Analysis
  • 5. Key geographic growth data
  • 6. Deep profiles top competitive companies

Table of Contents

Chap 1. Executive Summary

  • 1.1. Methodology

Chap 2. Market Overview

  • 2.1. Definition
  • 2.2. Key Findings
    • 2.2.1. Market Opportunities are in Asia Pacific
    • 2.2.2. Cardiovascular & Neurosurgery Dominates the Therapeutic Application Market
    • 2.2.3. Demand For Non Invasive Surgeries Is Driving The Market Growth
    • 2.2.4. Surgical Imaging Display Market Promising Great Future
    • 2.2.5. Imaging Systems Will Have The Highest Market Share Driven By Presence Of Major Diagnostic Imaging Companies
    • 2.2.6. Partnerships And Collaborations Are The Winning Strategies For The Market Players
  • 2.3. Key Buying Criteria
    • 2.3.1. Patient Care & Safety
    • 2.3.2. Price
    • 2.3.3. Success Rates
    • 2.3.4. Operating Room Design
  • 2.4. Value Chain Analysis
  • 2.5. Planning And Establishment Of Hybrid Operating Room
    • 2.5.1. Planning
    • 2.5.2. Design And Construction
    • 2.5.3. Location
    • 2.5.4. Imaging Devices
      • 2.5.4.1. Mobile & Fixed Systems
      • 2.5.4.2. Image Intensifier And Flat Panel Detector System
      • 2.5.4.3. Ceiling And Floor Mounted Systems

Chap 3. Market Determinants

  • 3.1. Drivers Of Hybrid Operating Rooms
    • 3.1.1. Healthcare Reforms Advancements In Healthcare Technologies Drive Product Innovation
    • 3.1.2. Benefits Over Conventional Operating Systems Drive Adoption
      • 3.1.2.1. Hybrid Or Provides Maximum Flexibility
      • 3.1.2.2. Clinical Decision Support Systems
    • 3.1.3. Increasing Number Of Ascs (Ambulatory Surgical Centers)
    • 3.1.4. Decreasing Mortality And Morbidity Demands For A Safer Operating Environment
    • 3.1.5. Growing Number Of Heart Patients Globally
    • 3.1.6. Hybrid Approach To Minimally Invasive Heart Surgery
    • 3.1.7. Smart Healthcare Will Drive Faster Adoption
    • 3.1.8. Global Increase In Healthcare Spending
    • 3.1.9. Increasing Number Of Surgeries
  • 3.2. Restraints Of Global Hybrid Operating Rooms Market
    • 3.2.1. High Cost Of Operating Room Equipment
  • 3.3. Market Opportunities
    • 3.3.1. Emerging Economies In Asia-Pacific And Latin America
    • 3.3.2. Technology Is The Key To Success
      • 3.3.2.1. Surgical Therapeutics
      • 3.3.2.2. Robotics

Chap 4. Market Segmentation By Applications

  • 4.1. Therapeutic
    • 4.1.1. Cardiovascular OR
      • 4.1.1.1. Globally CVD Burdens Almost All The Region
      • 4.1.1.2. Research And Development In CVD Therapeutics
    • 4.1.2. Neurosurgery
      • 4.1.2.1. Some Brands Of Neurological Monitors
    • 4.1.3. Thoracic Surgery
    • 4.1.4. Biopsy
    • 4.1.5. Orthopedic Surgeries
    • 4.1.6. Laparoscopic Surgeries
    • 4.1.7. Emergency Care
    • 4.1.8. Other Surgeries
  • 4.2. Diagnostic Imaging
    • 4.2.1. Fluoroscopy
    • 4.2.2. Digital Subtraction Angiography
    • 4.2.3. Three-Dimensional (3d) C-Arm Computed Tomography

Chap 5. Market Segmentation By Device

  • 5.1. Operating Tables
    • 5.1.1. Mobile Operating Tables
    • 5.1.2. Stationary Operating Tables
  • 5.2. Operating Room Lights
    • 5.2.1. Dimmable Lights
    • 5.2.2. Led Lighting
    • 5.2.3. Halogens
  • 5.3. Surgical Booms
  • 5.4. Surgical Imaging Displays
    • 5.5. Intraoperative Diagnostic Devices
    • 5.5.1. 3D Ultrasound
    • 5.5.2. MRI (Magnetic Resonance Imaging)
      • 5.5.2.1. Top Brands And Manufacturers Of MRI
    • 5.5.3. Computer Tomography
    • 5.5.4. Computer Assisted Robotic Surgery
    • 5.5.5. C-Arm X-Ray
    • 5.5.6. Infra Red Imaging Systems
  • 5.6. Operating Room Communication Systems
    • 5.6.1. Audio Visual
    • 5.6.2. Operating Room Integration System
      • 5.6.2.1. WiFi
      • 5.6.2.2. RFID
      • 5.6.2.3. PACS

Chap 6. Geographical Analysis

  • 6.1. North America
    • 6.1.1. United States (U.S.)
      • 6.1.1.1. Prevalent Diseases In US
      • 6.1.1.2. Diabetes In The US
      • 6.1.1.3. The US Regulations (FDA)
    • 6.1.2. Canada
      • 6.1.2.1. Diseases Prevalent In Canada
        • 6.1.2.1.1. Cardiovascular Diseases (CVD)
        • 6.1.2.1.2. Cancer
        • 6.1.2.1.3. Diabetes
      • 6.1.2.2. Regulations In Canada
  • 6.2. Europe
    • 6.2.1. Regulations Regarding Medical Devices In Europe
    • 6.2.2. Prevalent Diseases In Europe
    • 6.2.3. United Kingdom (UK)
      • 6.2.3.1. Diseases Prevalent In UK
    • 6.2.4. France
    • 6.2.5. Germany
      • 6.2.5.1. Diseases Prevalent In Germany
    • 6.2.6. Spain
    • 6.2.7. Italy
  • 6.3. Asia Pacific
    • 6.3.1. India
      • 6.3.1.1. Prevalence Of CVD And Other Heart Diseases In India
      • 6.3.1.2. Regulations In India
      • 6.3.1.3. Opportunities In India
    • 6.3.2. China
      • 6.3.2.1. Diseases Prevalent In China
        • 6.3.2.1.1. CVD
        • 6.3.2.1.2. Regulations In China
    • 6.3.3. Japan
      • 6.3.3.1. Diseases Prevalent In Japan
      • 6.3.3.2. Regulations In Japan
    • 6.3.4. Korea
      • 6.3.4.1. Regulations In Korea
  • 6.4. Rest Of The World
    • 6.4.1. Latin America
      • 6.4.1.1. Brazil
        • 6.4.1.1.1. Prevalent Diseases In Brazil
        • 6.4.1.1.2. Mexico
        • 6.4.1.1.3. Regulations
        • 6.4.1.1.4. Prevalence Of Diseases In Mexico

Chap 7. Competitive Landscape

  • 7.1. Key Strategies
    • 7.1.1. Partnerships
    • 7.1.2. Acquisitions
    • 7.1.3. Product Launch

Chap 8. Company Profiling

  • 8.1. Barco Nv
    • 8.1.1. Overview
    • 8.1.2. Barco Nv Products Portfolio In Hybrid Or
    • 8.1.3. Strategic Moves
    • 8.1.4. SCOT Analysis
  • 8.2. Cook Medical
    • 8.2.1. Overview
    • 8.2.2. Cook Medical Products Portfolio In Hybrid OR
    • 8.2.3. SCOT Analysis
  • 8.3. Eschmann Equipment
    • 8.3.1. Overview
    • 8.3.2. Eschmann Product Portfolio In Hybrid OR
    • 8.3.3. SCOT Analysis
  • 8.4. GE Healthcare
    • 8.4.1. Overview
    • 8.4.2. GE Healthcare Product Portfolio In Hybrid Or
    • 8.4.3. Strategic Moves
    • 8.4.4. SCOT Analysis
  • 8.5. Johnson & Johnson
    • 8.5.1. Overview
    • 8.5.2. Johnson & Johnson Products Portfolio In Hybrid OR
    • 8.5.3. SCOT Analysis
  • 8.6. Karl Storz Gmbh & Co. KG
    • 8.6.1. Overview
    • 8.6.2. Karl Storz Product Portfolio In Hybrid OR
    • 8.6.3. Strategic Moves
    • 8.6.4. SCOT Analysis
  • 8.7. Maquet Getinge Group
    • 8.7.1. Overview
    • 8.7.2. Maquet Product Portfolio In Hybrid OR
    • 8.7.3. Strategic Moves
    • 8.7.4. SCOT Analysis
  • 8.8. Mediflex
    • 8.8.1. Overview
    • 8.8.2. Mediflex Product Portfolio In Hybrid OR
    • 8.8.3. SCOT Analysis
  • 8.9. Mizuho OSI
    • 8.9.1. Overview
    • 8.9.2. Mizuho OSI Product Portfolio In Hybrid OR
    • 8.9.3. Strategic Moves
    • 8.9.4. SCOT Analysis
  • 8.10. NDS Surgical Imaging, LLC
    • 8.10.1. Overview
    • 8.10.2. NDS Surgical Imaging Product Portfolio In Hybrid OR
    • 8.10.3. Strategic Moves
    • 8.10.4. SCOT Analysis
  • 8.11. Philips Healthcare
    • 8.11.1. Overview
    • 8.11.2. Phillips Healthcare Products Portfolio In Hybrid OR
    • 8.11.3. Strategic Moves
    • 8.11.4. SCOT Analysis
  • 8.12. Siemens Healthcare GMBH
    • 8.12.1. Overview
    • 8.12.2. Siemens Healthcare Products Portfolio In Hybrid OR
    • 8.12.3. Strategic Moves (2013-14)
    • 8.12.4. SCOT Analysis
  • 8.13. Sisco Ltd
    • 8.13.1. Overview
    • 8.13.2. Sisco Product Portfolio In Hybrid OR
    • 8.13.3. SCOT Analysis
  • 8.14. Sklar
    • 8.14.1. Overview
    • 8.14.2. Sklar Product Portfolio In Hybrid OR
    • 8.14.3. SCOT Analysis
  • 8.15. Skytron, LLC
    • 8.15.1. Overview
    • 8.15.2. Skytron Product Portfolio In Hybrid OR
    • 8.15.3. Strategic Moves
    • 8.15.4. SCOT Analysis
  • 8.16. Sontec Instruments
    • 8.16.1. Overview
    • 8.16.2. Sontec Instruments Product Portfolio In Hybrid OR
    • 8.16.3. Strategic Moves
    • 8.16.4. SCOT Analysis
  • 8.17. Steris Corporation
    • 8.17.1. Overview
    • 8.17.2. Steris Product Portfolio In Hybrid OR
    • 8.17.3. SCOT Analysis
  • 8.18. Stryker Corporation
    • 8.18.1. Overview
    • 8.18.2. Stryker Product Portfolio In Hybrid OR
    • 8.18.3. Strategic Moves
    • 8.18.4. SCOT Analysis
  • 8.19. Toshiba Medical Systems
    • 8.19.1. Overview
    • 8.19.2. Toshiba Medical System Products Portfolio In Hybrid OR
    • 8.19.3. Strategic Moves
    • 8.19.4. SCOT Analysis
  • 8.20. Trumpf Gmbh + Co. KG
    • 8.20.1. Overview
    • 8.20.2. Trumpf Product Portfolio In Hybrid OR
    • 8.20.3. Strategic Moves
    • 8.20.4. SCOT Analysis
Back to Top